Proton and heavy ion radiotherapy: Effect of LET

Similar documents
Radiation qualities in carbon-ion radiotherapy at NIRS/HIMAC

Peak temperature ratio of TLD glow curves to investigate the spatial variation of LET in a clinical proton beam

Cancer Treatment by Charged Particles - Carbon Ion Radiotherapy -

Progress of Heavy Ion Therapy

Biological Optimization of Hadrontherapy. Uwe Oelfke

ADVANCES IN RADIATION TECHNOLOGIES IN THE TREATMENT OF CANCER

HEAVY PARTICLE THERAPY

New Treatment Research Facility Project at HIMAC

PTCOG 46. Educational Workshop Session IV. Head & Neck CLINICAL. J. Mizoe (NIRS, Japan)

TFY4315 STRÅLINGSBIOFYSIKK

Heavy Ion Tumor Therapy

Specifics of treatment planning for active scanning and IMPT

Status of H 1 and C 12

Proton Therapy: Where Are We Now and Where Are We Going? Erin Davis MSN, CRNP, ACNP BC Lead Nurse Practitioner

Characterization and implementation of Pencil Beam Scanning proton therapy techniques: from spot scanning to continuous scanning

III. Proton-therapytherapy. Rome SB - 5/5 1

*Chien-Yi Yeh, Ji-Hong Hong * 葉健一洪志宏

Proton and helium beams: the present and the future of light ion beam therapy

PHYS 383: Applications of physics in medicine (offered at the University of Waterloo from Jan 2015)

Treatment Planning (Protons vs. Photons)

PROGRESS IN HADRONTHERAPY

Proton Therapy Dosimetry & Clinical Implementation. Baldev Patyal, Ph.D., Chief Medical Physicist Department of Radiation Medicine

Proton Beam Therapy at Mayo Clinic

COMPARISON OF RADIOBIOLOGICAL EFFECTS OF CARBON IONS TO PROTONS ON A RESISTANT HUMAN MELANOMA CELL LINE

Present status and future of Proton beam therapy

Nuclear Data for Radiation Therapy

Fractionation: why did we ever fractionate? The Multiple Fractions School won! Survival curves: normal vs cancer cells

Assistant Professor Department of Therapeutic Radiology Yale University School of Medicine

Review of Hadron machines for cancer therapy

Hampton University Proton Therapy Institute

Modelling the induction of cell death and chromosome damage by therapeutic protons

Therapeutic Medical Physics. Stephen J. Amadon Jr., Ph.D., DABR

First, how does radiation work?

Particle Radiation Therapy. Sophi Farid Phys 3305 Southern Methodist University Spring 2016

Calculated LET spectrum from antiproton beams stopping in water

ACCELERATOR DESIGN ISSUES IN CANCER THERAPY

LET, RBE and Damage to DNA

Uncertainties in proton therapy: Analysis of the effects of density changes, calibration curve errors and setup errors in proton dose distributions.

Advances in external beam radiotherapy

Considerations when treating lung cancer with passive scatter or active scanning proton therapy

The Advantages of Particle Therapy and the Status of the Heidelberg Iontherapy Center

Potential benefits of intensity-modulated proton therapy in head and neck cancer van de Water, Tara Arpana

Proton Treatment. Keith Brown, Ph.D., CHP. Associate Director, Radiation Safety University of Pennsylvania

Discuss the general planning concepts used in proton planning. Review the unique handling of CTV / ITV / PTV when treating with protons

Ion Beam Therapy should we prioritise research on helium beams?

Review of Heavy Ion Accelerators for Hadrontherapy

FROM ICARO1 TO ICARO2: THE MEDICAL PHYSICS PERSPECTIVE. Geoffrey S. Ibbott, Ph.D. June 20, 2017

MEDICAL PHYSICS ASPECTS OF PARTICLE THERAPY Oliver Jäkel 1,2, *

MEDICAL MANAGEMENT POLICY

Today, I will present the second of the two lectures on neutron interactions.

This content has been downloaded from IOPscience. Please scroll down to see the full text.

Use of radiation to kill diseased cells. Cancer is the disease that is almost always treated when using radiation.

Neutron Radiotherapy: Past, Present, and Future Directions

Hypofractionation in particle therapy. Marco Durante

SCIENTIFIC AND TECHNOLOGICAL DEVELOPMENT OF HADRONTHERAPY

Neutrons. ρ σ. where. Neutrons act like photons in the sense that they are attenuated as. Unlike photons, neutrons interact via the strong interaction

IMPT with Carbon Ions

Figure 1.1 PHITS geometry for PTB irradiations with: broad beam, upper panel; mono energetic beams, lower panel. Pictures of the setups and of the

Proton Stereotactic Radiotherapy: Clinical Overview. Brian Winey, Ph.D. Physicist, MGH Assistant Professor, HMS

Proton therapy for prostate cancer

Look! Borg get upgrade already!

Radiobiological principles of brachytherapy

Sarcoma and Radiation Therapy. Gabrielle M Kane MB BCh EdD FRCPC Muir Professorship in Radiation Oncology University of Washington

Clinical application of intensity and energy modulated r adiother apy with photon and electron beams. Xiangkui Mu

8/3/2016. Clinical Significance of RBE Variations in Proton Therapy. Why RBE (relative biological effectiveness)?

Introduction to Ion Beam Cancer Therapy

Nature of Radiation and DNA damage

Corporate Medical Policy

Comparative Treatment Planning in Radiotherapy and Clinical Impact of Proton Relative Biological Effectiveness

State-of-the-art proton therapy: The physicist s perspective

Medical physics is beautiful

La ricerca e la terapia in adroterapia-2. R.Orecchia / P. Fossati

IN VIVO IMAGING Proton Beam Range Verification With PET/CT

Clinical considerations of RBE in proton therapy

Status of Proton Therapy: results and future trends

6/29/2012 WHAT IS IN THIS PRESENTATION? MANAGEMENT OF PRIMARY DEVICES INVESTIGATED MAJOR ISSUES WITH CARDIAC DEVICES AND FROM MED PHYS LISTSERVS

PRINCIPLES and PRACTICE of RADIATION ONCOLOGY. Matthew B. Podgorsak, PhD, FAAPM Department of Radiation Oncology

POSTGRADUATE INSTITUTE OF MEDICINE UNIVERSITY OF COLOMBO MP (CLINICAL ONCOLOGY) PART I EXAMINATION - AUGUST Time : p.m p.m.

PRESCRIBING RECORDING AND REPORTING PROTON BEAM THERAPY ICRU 78. RAJESH THIYAGARAJAN Senior Medical Physicist & RSO Medanta The Medicity

Role of protons, heavy ions and BNCT in brain tumors

Dr. Robert R. Wilson, a physicist who had worked on

Particle Therapy Systems by Mitsubishi Electric DG1101-KM-0034

Protons Monte Carlo water-equivalence study of two PRESAGE formulations for proton beam dosimetry J. Phys.: Conf. Ser.

Multi-Ion Analysis of RBE using the Microdosimetric Kinetic Model

Two-Dimensional Thermoluminescence Dosimetry System for Proton Beam Quality Assurance

Basic Press Information

Tumor Therapy with Heavy Ions at GSI Darmstadt

Planning for the Installation of a Compact Superconducting Proton Therapy Unit in a Busy Medical Center Environment

ACR TXIT TM EXAM OUTLINE

The impact of different radiation qualities on cancer cells

Future Directions in Prostate Cancer: The Case for Protons. John J. Coen, MD Helen & Harry Gray Cancer Center

Learning Objectives. Clinically operating proton therapy facilities. Overview of Quality Assurance in Proton Therapy. Omar Zeidan

Radiobiological Characterization of Clinical Proton and Carbon-Ion Beams

Activities at the Heidelberg Ion Therapy Center (HIT)

BENEFITS Reduced side effects Better quality of life outcomes Minimal disruption to daily life Proven to be effective among all age groups

Clinical Protontherapy Head and Neck cancer

An introduction to medical imaging and radiotherapy: Current status and future directions I

Applications of Particle Accelerators

NCCN GUIDELINES ON PROTON THERAPY (AS OF 4/23/18) BONE (Version , 03/28/18)

Transcription:

Proton and heavy ion radiotherapy: Effect of LET As a low LET particle traverses a DNA molecule, ionizations are far apart and double strand breaks are rare With high LET particles, ionizations are closer together and double strand breaks are more common

Effect of LET on cell survival curves Cell sensitivity increases as LET increases The increase in sensitivity is represented by the RBE RBE 60 dose of Co radiation dose of different LET radiation to produce the same biological effect

Factors which influence the RBE RBE depends upon: radiation quality (LET) radiation dose dose/fraction dose rate biological system or endpoint

Effect of dose and dose/fraction on The RBE is low for high doses (=1.5) The RBE is high for low doses (=3.0) The RBE is high for low doses/fraction (=2.6) the RBE for neutrons

Effect of dose and dose/fraction on the RBE At low doses (and low doses/fraction), the RBE will be higher since there is more repair at low doses and this favors the standard 60 Co radiation the numerator in the RBE equation increases as dose decreases A similar effect is seen with low doserate irradiation

RBE dependence on the type of cell irradiated In general, cells which exhibit large shoulders in their survival curves will have high RBEs Conversely, cells with little, if any, shoulder will have low RBEs But there are exceptions due to the different interaction mechanisms between low- and high-let radiations e.g. cell-cycle effect

Variation of RBE and As LET increases: OER with LET RBE increases and OER decreases

Influence of LET on cell-cycle effect For high-let radiations the cell-cycle effect is less than with low LET radiations cancer cells or late reacting normal tissue cells trapped in resistant phases of the cell cycle will be less protected when treated with high-let radiations

Why high-let radiotherapy? Physical benefits the Bragg peak reduced penumbra Radiobiological benefits reduced effect of hypoxia reduced cell cycle effect

Why protons? The major reason is physical the Bragg peak

Depth-dose characteristics of high-energy protons The depth of the Bragg peak can be adjusted by changing beam energy (Jones, 2006)

The Bragg peak Depth can be changed by varying the energy Too narrow for all but very small lesions Can be widened by mixing beams of several energies using a range filter (diluted Bragg peak)

Variable range shifter The number of slabs of the range shifter are varied to modulate the energy of the beam reaching the patient in order to produce the spread out Bragg peak The patient specific compensator is designed to shape the distal extent of the high dose region

Spreading out the proton Bragg peak By using 12 slabs of range shifter in this example it is possible to produce a spread out Bragg peak of uniform intensity from 15 to 40 mm in depth

Biological benefits within the spread out Bragg peak Because the spread out Bragg peak contains protons from the low-let plateau region, the average LET is not very high biological benefits such as reduced effects of oxygen and the cell cycle will be greatly reduced

Proton treatment for macular degeneration using the Bragg peak For beams that do not need to be spread out, the LET of the protons remains high Biological benefits of high LET radiations are maintained Moyes et al, Medical Physics 26, 777, 1999

Partial breast irradiation using the spread-out Bragg peak

Target volume DVHs for this breast treatment by different modalities Weber, 2006

Heart DVHs for this patient Weber, 2006

Ipsilateral lung DVHs for this patient Weber, 2006

Comparisons of protons, IMRT, and conventional photons for breast treatments

IMRT vs. protons Comparative dose distributions for (a) IMRT and (b) protons for a recurrent sarcoma in a 12-year-old boy (Jones, 2006)

Proton beam treating an intracranial lesion

Comparison of protons and IMRT Lomax, et al, Radiotherapy and Oncology 51, 257, 1999

Intensity Modulated Proton Therapy (IMPT) In intensity modulated proton therapy, a narrow proton pencil beam is scanned magnetically over the target volume, while both the energy and the intensity of the beam are modulated

Intensity Modulated Proton Therapy (IMPT) (From the German Cancer Research Centre)

Intensity and energy modulation with protons

Iterative DVH modification for this patient

Proton IMPT vs. photon IMRT for prostate cancer Oelfke, (2003)

Proton IMRT for a rhabdomyosarcoma Example of an intensitymodulated proton therapy plan with sparing of the lacrimal gland for a 12-yearold boy with an orbital rhabdomyosarcoma initially infiltrating the surrounding soft tissue Timmermann, 2006

Why heavy ions? Physical advantages: Bragg peak adjustable Bragg peak depth sharp beam edges (small penumbra) Biological advantages: potentially low OER, reduced cell-cycle effect

Why heavy ions work

Carbon ion Bragg peaks

Carbon ions vs. protons Bragg peaks with heavy ions are much narrower than those for protons and the dose in the plateau region is lower

Biological effectiveness within the spread out Bragg peak Compared with protons, the Bragg peak for heavy ions is much higher and the radiation within the Bragg peak has a much higher LET Consequently, when the Bragg peak is spread out, much of the biological benefit is retained

Changes of RBE with depth for spread-out Bragg peaks Within the spread out Bragg peak, LET (and RBE) will be highest at the distal end of the beam where there is less plateau region contamination To get a uniform biologically effective dose throughout the target volume, the physical dose must be higher at the proximal side of the beam

400 MeV C-ion Bragg peak diluted using 6-step Lucite range shifter

Heavy ion therapy A schematic diagram of a synchrotron treatment center (Jones, 2006)

Active raster scan system for C ions at GSI, Darmstadt, Germany Instead of a shaped collimator beams can be shaped by active raster scanning The energy of the beam can be continuously adjusted, thus avoiding the need for a physical range shifter

Scattering of heavy ions Multiple scattering is reduced considerably as the size of the particle increases this reduces the penumbra Kempe, 2007

Penumbra decreases as atomic number increases Kempe, 2007

Physical and biological advantages of different types of radiotherapy

Heavy ions Disadvantages: Very large Very expensive

Benefit vs. Cost From van Dyk, Vol. 2

Summary: applications and relative costs of different modalities

Particle therapy facilities worldwide

Over 60,000 proton and 5,000 carbon ion patients treated

Proton and heavy ion radiotherapy: Summary The Bragg peak provides significant dose distribution advantages Because the Bragg peak is so narrow it needs to be spread out The average LET in the proton spread out Bragg peak is too low for any biological benefit With heavy ions the biological benefit is retained Heavy ion radiotherapy machines are very expensive